Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Nov;28(6):584-7.
doi: 10.1046/j.1365-2230.2003.01378.x.

A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema

M C A Polderman  1 , J C M Govaert, S le Cessie, S Pavel
Affiliations
Clinical Trial

A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema

M C A Polderman et al. Clin Exp Dermatol. 2003 Nov.

Abstract

We carried out a randomized, double-blind, placebo-controlled study to examine the therapeutic effect of UVA-1 irradiation on dyshidrotic hand eczema. Twenty-eight patients were randomised to receive UVA-1 irradiation (40 J/cm2) or placebo, five times a week for 3 weeks. Evaluated by the DASI and the VAS, UVA-1 was significantly more effective after 2 and 3 weeks. Also, desquamation and area of affected skin improved significantly more after UVA-1. We did not find any difference regarding the response of patients with increased IgE blood levels (>100 IU/mL) compared with those having normal IgE levels. No side effects were observed. This study indicates that UVA-1 can cause a significant improvement of both objective and subjective signs of dyshidrotic eczema.

PubMed Disclaimer

Publication types